Mr Steve Schaefer, Executive Board Member & General Counsel
Tarilian Laser Technologies
Mr David Pearce, Non Executive Director
USA 2018 (pdf) Presentation - IDTechEx*
USA 2018 (audio) Presentation - IDTechEx*
If you already have access, please [Login]
Access is available via an IDTechEx Market Intelligence Subscription
Company Profile (Tarilian Laser Technologies)
View Tarilian Laser Technologies Timeline
Tarilian Laser Technologies (TLT) is a Medtech Company based in Welwyn Garden City, Hertfordshire, United Kingdom ( Head Office and Labs). Our main clinical centre is The Barts Heart Centre in London, Europe's largest cardiovascular research centre.
Please see: www.tarilian.co.uk - On the front page, you will be able to directly access the 30 minute Bloomberg World-Wide Business Interview that summarises TLT.
TLT is an advanced Medtech SME and is 13485(2016) registered with solid competencies in medical engineering, research & development, clinical trials, regulatory affairs and early commercialisation.
At TLT, we have developed a novel optical platform based on our internal proprietary patented opto-electronic micro-sensor for full haemodynamic profiling including our ability to generate beat to beat blood pressure, compliance data, cardiac output and regional blood flow and blood pressure. A unique aspect of the TLT Sapphire sensor is that no energy enters the body at all - hence it is truly NON-invasive and also we do not require any compression/ cuff and nor do we require any calibration in any manner.
Company Profile (ViCardio Limited)
View ViCardio Limited Timeline
The ViCardio® solution is the first commercial offering of the novel TLT blood pressure sensor that has been developed by its parent company Tarilian Laser Technologies over the last 5 years.
Unlike other attempts at cuffless technology over the past 50 years, which have proved problematic and highly inaccurate, the TLT team have broken a major barrier developing a high-fidelity system that easily and without any energy entering the body accurately and effectively generates the most important surface physiological parameters that determine blood pressure. This patented technology will create a whole new series of applications in consumer and hospital care.